SL
JAZZ icon

Signition LP’s Jazz Pharmaceuticals JAZZ Stock Holding History

Signition LP’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-7,698
Closed -$1.1M – 127
2019
Q2 		$1.1M Sell
7,698
-1,719
-18% -$231K 0.72% 57
2019
Q1 		$1.35M Buy
9,417
+747
+9% +$97.4K 0.91% 49
2018
Q4 		$1.07M Sell
8,670
-140
-2% -$20.8K 0.69% 56
2018
Q3 		$1.48M Buy
+8,810
New +$1.52M 0.75% 47

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Signition LP's JAZZ Position: Q3 2019 in Review

Signition LP sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2019, closing a stake of 7,698 shares — an estimated $1.1M sold.

Signition LP first reported a position in JAZZ in Q3 2018 and held it in 4 quarters. The position peaked at $1.48M in Q3 2018. 406 funds tracked by Wall St. Rank hold JAZZ as of Q3 2019.

  • Signition LP reported no remaining Jazz Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Signition LP sold 7,698 Jazz Pharmaceuticals shares in Q3 2019, an estimated $1.1M.
  • Signition LP first reported a position in Jazz Pharmaceuticals in Q3 2018 and held it in 4 quarters.
  • Signition LP's Jazz Pharmaceuticals position peaked at $1.48M in Q3 2018.
  • 406 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2019.

Based on Signition LP's 13F filing for Q3 2019, filed 5 Nov 2019.